Universe Pharmaceuticals (UPC) Enterprise Value (2020 - 2025)

Universe Pharmaceuticals (UPC) has 6 years of Enterprise Value data on file, last reported at -$33.6 billion in Q3 2025.

• For the quarter ending Q3 2025, Enterprise Value fell 8.8% year-over-year to -$33.6 billion; the trailing twelve-month figure through Sep 2025 stood at -$33.6 billion (down 8.8% YoY), and the FY2025 full-year result was -$33.6 billion, down 8.8% from the prior year.
• Enterprise Value declined to -$33.6 billion in Q3 2025, from -$30.9 billion in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$11.4 million in Q1 2024 to a low of -$33.6 billion in Q3 2025.
• A 5-year average of -$9.4 billion and a median of -$2.7 billion in 2022 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value sank 24355.18% in 2022 and soared 56.64% in 2024, its largest moves.
• Tracing UPC's Enterprise Value over 5 years: stood at -$23.4 million in 2021, then slumped by 24355.18% to -$5.7 billion in 2022, then gained by 7.65% to -$5.3 billion in 2023, then tumbled by 484.03% to -$30.9 billion in 2024, then decreased by 8.8% to -$33.6 billion in 2025.
• Business Quant data shows UPC's Enterprise Value at -$33.6 billion in Q3 2025, -$30.9 billion in Q3 2024, and -$11.4 million in Q1 2024.